PharmAust (ASX:PAA) Price-to-Operating-Cash-Flow : (As of May. 27, 2024)

View and export this data going back to 2001. Start your Free Trial

What is PharmAust Price-to-Operating-Cash-Flow?

As of today (2024-05-27), PharmAust's share price is A$0.185. PharmAust's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00. Hence, PharmAust's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for PharmAust's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:PAA's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.24
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

PharmAust's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -7.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 14.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 12.50% per year.

During the past 13 years, PharmAust's highest 3-Year average Operating Cash Flow per Share Growth Rate was 63.30% per year. The lowest was -51.80% per year. And the median was 30.30% per year.

PharmAust Price-to-Operating-Cash-Flow Historical Data

The historical data trend for PharmAust's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmAust Price-to-Operating-Cash-Flow Chart

PharmAust Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

PharmAust Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PharmAust's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, PharmAust's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmAust's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmAust's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PharmAust's Price-to-Operating-Cash-Flow falls into.

PharmAust Price-to-Operating-Cash-Flow Calculation

PharmAust's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.185	/	-0.003
	=

PharmAust's Share Price of today is A$0.185.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PharmAust's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

PharmAust Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PharmAust's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmAust (ASX:PAA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmAust Ltd (ASX:PAA) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ECQ:Germany ECQ:Germany

Address

1 Kyle Way, Suite 116, Claremont, Perth, WA, AUS, 6010

Website

https://www.pharmaust.com

PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.